Assignment of Assignor's Interest

Recorded: 2019-05-09 Pages: 6

Assignors

KAMIN, MARC

Executed: 2019-04-25

VERNILLET, LAURENT

Executed: 2019-04-25

Assignee

SK BIOPHARMACEUTICALS CO., LTD.

221 PANGYOYEOK-RO, BUNDANG-GU, SEONGNAM-SI, GYEONGGI-DO, 13494, KOREA, REPUBLIC OF

Covered Property (1)

Use Of [(1R)-1-(2-Chlorophenyl)-2-(Tetrazol-2-YL)Ethyl] Carbamate In Combination Therapy

Application: 16/348,630 →

Publication: US 2019/0365709